Baroda BNP Paribas Manufacturing Fund - Regular Plan - IDCW Option
Category: Equity: Thematic-Manufacturing
Launch Date: 28-06-2024
AUM:
₹ 1,242.88 Cr
Expense Ratio
2.16%
Benchmark
Nifty India Manufacturing TRI
ISIN
INF251K01TN2
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
500
Fund Manager
Mr. Jitendra Sriram, Mr. Kushant Arora
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Baroda BNP Paribas Manufacturing Fund - Regular Plan - IDCW Option | -2.1 | - | - |
| Nifty India Manufacturing TRI | -1.97 | 20.19 | 24.63 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
9.5025
Last change
-0.05 (-0.4778%)
Fund Size (AUM)
₹ 1,242.88 Cr
Performance
-4.87% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
TThe investment objective is to generate long-term capital appreciation from a portfolio invested predominantly in equity and equity related securities of companies engaged in the Manufacturing.
Fund Manager
Mr. Jitendra Sriram, Mr. Kushant Arora
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.12 |
| RELIANCE INDUSTRIES LIMITED EQ | 7.45 |
| BOSCH LIMITED EQ NEW FV RS.10/- | 4.97 |
| HITACHI ENERGY INDIA LIMITED EQ | 4.22 |
| MAHINDRA AND MAHINDRA LIMITED EQ NEW F.V. RS.5 | 3.94 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 3.34 |
| VEDANTA LIMITED EQ NEW RS.1/- | 3.08 |
| Dr. Reddys Laboratories Ltd | 2.94 |
| ASTRAZENECA PHARMA INDIA LIMITED EQ NEW FV RS.2/- | 2.53 |
| SUMITOMO CHEMICAL INDIA LIMITED EQ | 2.35 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Capital Goods | 22.86 |
| Healthcare | 21.74 |
| Automobile and Auto Components | 21.06 |
| Oil, Gas & Consumable Fuels | 12.51 |
| Chemicals | 9.1 |
| Metals & Mining | 4.69 |
| Diversified | 1.45 |
| Construction Materials | 1.07 |
| Power | 1.05 |